No Detail Found!

Efficacy of Ganglioside GM1 in the Treatment of Postherpetic Neuralgia.

Author(s)
Ram Prasad Koju Department of Dermatology, Renmin Hospital of Wuhan University, Wuhan 430060, China
TieChi Lei Department of Dermatology, Renmin Hospital of Wuhan University, Wuhan 430060, China
Abstract
Postherpetic neuralgia (PHN) is a commonest and difficult-to-manage complication of Herpes zoster. This comparative study included 140 cases of PHN admitted in the department of dermatology in Renmin Hospital of Wuhan University, Wuhan, China, from March 2014 to February 2015, divided into a control and a study group. In addition to the combination of antiviral, analgesic, and neurotrophic agents given to the control group, additional ganglioside GM1 was given to patients in the study group. Pain assessment was performed at the time of admission, and then on the third, seventh and tenth day of treatment, on both groups, using a 10 cm visual analogue scale (VAS). There was a significant statistical difference between the pain VAS score of the two groups, on the seventh day (3.73 ±1.66 vs. 3.03 ±1.86, p=0.024) and on the tenth day (3.25 ±1.78 vs. 2.20 ±1.59, p=0.006) of treatment. The number of patients who have good /and complete response (37.5%) were largely higher in the study group than those in the control group (15%, p < 0.05). This finding demonstrates that the administration of ganglioside GM1 may potentially serve as a neoadjuvant therapy to reduce the severity and duration of pain in PHN patients.
Publication Details
Page(s) 633-634
DOI DOI not available
Published Journal: Journal of College of Physicians and Surgeons--Pakistan : JCPSP, Volume: 26, Issue: 7, Year: 2016

Request the full text from PASTIC

Keywords
Postherpetic neuralgia. Ganglioside GM1. Visual analogue scale.
References
BairdNL,YuX,CohrsRJ,GildonD., 2013.Varicella zoster virus (VZV) - Human neuron interaction,Viruses 5 2106 -15
SchmaderK,GnannJW,WatsonCP, 2008.The epidemiological, clinical, and pathological rationale for the Herpes zoster vaccine,J Infect Dis 197 S207 -15
LangPO, 2011.Herpes zoster vaccine: What are the potential benefits for the ageing and older adults,EGM 2 134 -9
GalluzziKE, 2009.Managing Herpes zoster and postherpetic neuralgia,J Am Osteopath Assoc 109 S7 -S12
SandhoffK,HarzerK., 2013.Gangliosides and gangliosidoses: principles of molecular and metabolic pathogenesis,J Neurosci 33 10195 -208
ZhuY,YangJ,JiaoS,JiT, 2013.Ganglioside-monosialic acid (GM1) prevents oxaliplatin-induced peripheral neurotoxicity in patients with gastrointestinal tumors,World J Surg Oncol 11 19 -
0

Citations

0

Downloads

98

Views